Literature DB >> 8899000

Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia.

K Fudge1, D G Bostwick, M E Stearns.   

Abstract

BACKGROUND: The objective of this study was to evaluate the expression of platelet-derived growth factor (PDGF A, PDGF B) and their receptors (PDGF alpha, PDGF beta) in prostatic intraepithelial neoplasia (PIN) and adenocarcinoma.
METHODS: Peroxidase-antiperoxidase immunoperoxidase labeling was used to detect the extent of antibody labeling in 29 different high grade PIN specimens.
RESULTS: PDGF A and PDGF alpha were uniformly expressed in glandular epithelial and stromal cells, whereas PDGF B was not expressed by either tissue. However, PDGF beta was lightly expressed in a uniform manner by both the glandular epithelial and stromal cells.
CONCLUSIONS: The data suggest that an autocrine loop may exist in which the epithelial cells of high-grade PIN express PDGF AA and PDGF alpha to modulate growth of precancerous lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899000     DOI: 10.1002/(SICI)1097-0045(199611)29:5<282::AID-PROS2>3.0.CO;2-C

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

1.  Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

Authors:  Gary E Gallick; Paul G Corn; Amado J Zurita; Sue-Hwa Lin
Journal:  Future Med Chem       Date:  2012-01       Impact factor: 3.808

2.  Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer.

Authors:  Danni Li; Hanching Chiu; Vinita Gupta; Daniel W Chan
Journal:  Clin Chim Acta       Date:  2012-06-18       Impact factor: 3.786

3.  A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.

Authors:  Carolyn V Ustach; Wei Huang; M Katie Conley-LaComb; Chen-Yong Lin; Mingxin Che; Judith Abrams; Hyeong-Reh Choi Kim
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

4.  Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction.

Authors:  Abdo J Najy; Young Suk Jung; Joshua J Won; M Katie Conley-LaComb; Allen Saliganan; Chong Jai Kim; Elisabeth Heath; Michael L Cher; R Daniel Bonfil; Hyeong-Reh Choi Kim
Journal:  Prostate       Date:  2011-12-27       Impact factor: 4.104

5.  PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.

Authors:  M Katie Conley-LaComb; Wei Huang; Shihua Wang; Dongping Shi; Young Suk Jung; Abdo Najy; Rafael Fridman; R Daniel Bonfil; Michael L Cher; Yong Q Chen; Hyeong-Reh Choi Kim
Journal:  Am J Pathol       Date:  2011-12-28       Impact factor: 4.307

6.  PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types.

Authors:  A Mishra; A K Ormerod; M L Cibull; B T Spear; S D Kraner; D M Kaetzel
Journal:  Cancer Gene Ther       Date:  2008-11-07       Impact factor: 5.987

7.  In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.

Authors:  Marion T Weigel; Linda Dahmke; Christian Schem; Dirk O Bauerschlag; Katrin Weber; Peter Niehoff; Maret Bauer; Alexander Strauss; Walter Jonat; Nicolai Maass; Christoph Mundhenke
Journal:  BMC Cancer       Date:  2010-08-09       Impact factor: 4.430

8.  Morphoproteomic confirmation of a constitutively activated mTOR pathway in high grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Robert E Brown; George Zotalis; Ping L Zhang; Bihong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer.

Authors:  Janna Paulsson; Tobias Sjöblom; Patrick Micke; Fredrik Pontén; Göran Landberg; Carl-Henrik Heldin; Jonas Bergh; Donal J Brennan; Karin Jirström; Arne Ostman
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

10.  Phase II study of sunitinib in men with advanced prostate cancer.

Authors:  M Dror Michaelson; M M Regan; W K Oh; D S Kaufman; K Olivier; S Z Michaelson; B Spicer; C Gurski; P W Kantoff; M R Smith
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.